InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
7
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Brittenham Marissa, Directrice de la Stratégie. Director active across 1 company, notably Surgery Partners, Inc.. Aggregated, 12 disclosures have been published. Split: 0 buy · 7 sells. Total volume traded: €703k. History available since 1 February 2022. The latest transaction was disclosed on 13 March 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Brittenham Marissa
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
3,657 shares@ US$12.542.5% of flowCommon StockSEC:0001638833-26-000033:0
8,785 shares@ US$13.706.2% of flowCommon StockSEC:0001638833-26-000019:0
3,156 shares@ US$24.093.6% of flowCommon StockSEC:0001638833-25-000066:0
10,084 shares@ US$23.8011.7% of flowCommon StockSEC:0001638833-25-000047:0
14,700 shares@ US$25.6118.6% of flowCommon StockSEC:0001638833-25-000026:0
25,110 shares0Common StockSEC:0001638833-25-000013:0
1,284 shares@ US$30.171.8% of flowCommon StockSEC:0001638833-24-000058:0
2,886 shares@ US$31.184.3% of flowCommon StockSEC:0001638833-24-000044:0
1,637 shares@ US$31.892.5% of flowCommon StockSEC:0001638833-24-000010:0
7,608 shares@ US$32.8612.0% of flowCommon StockSEC:0001638833-23-000034:0
1,320 shares@ US$35.902.2% of flowCommon StockSEC:0001638833-23-000006:0
10,602 shares@ US$44.8025.3% of flowCommon StockSEC:0001638833-22-000014:0
12 of 12 declarations
About Brittenham Marissa
Marissa Brittenham is Directrice de la Stratégie and Chief Strategy Officer at Surgery Partners, Inc. She has 12 filings in total, and across the recent sample of 12 filings, sells total EUR 702735, with activity from 2022-02-03 to 2026-03-16. The modal transaction nature is Cession.
